Application of an immunocapillary electrophoresis assay to the detection of abnormal prion protein in brain, spleen and blood speciemens from patients with variant Creuzfeldt-Jakob disease

Journal of General Virology

Volumn 87, Issue 10, 2006, Pages 3119-3124

  Lourenco, Paula C ^a   Schmerr, Mary Jo ^b   MacGregor, Ian ^c   Will, Robert G ^a   Ironside, James W ^a   Head, Mark W ^a  

^a WESTERN GENERAL HOSPITAL   (United Kingdom)

^b IOWA STATE UNIVERSITY   (United States)

^c National Science Laboratory   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

FLUORESCENT DYE; ORGANIC SOLVENT; POLYCLONAL ANTIBODY; PRION PROTEIN; SYNTHETIC PEPTIDE;

AMINO ACID SEQUENCE; ANTIBODY SPECIFICITY; ARTICLE; BRAIN TISSUE; CAPILLARY ELECTROPHORESIS; CLINICAL ARTICLE; CONTROLLED STUDY; CREUTZFELDT JAKOB DISEASE; DIAGNOSTIC TEST; FLUORESCENCE; HUMAN; IMMUNOASSAY; LASER; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN DETERMINATION; SCRAPIE; SCREENING TEST; SENSITIVITY AND SPECIFICITY; SOLVENT EXTRACTION; SPLEEN; TISSUE LEVEL;

BRAIN; CREUTZFELDT-JAKOB SYNDROME; ELECTROPHORESIS, CAPILLARY; HUMANS; PRPSC PROTEINS; SPLEEN;

ANIMALIA; OVIS ARIES;

EID: 33749066765     PISSN: 00221317     EISSN: None     Source Type: Journal    
DOI: 10.1099/vir.0.81935-0     Document Type: Article

References (33)

1. Barletta, J. M., Edelman, D. C., Highsmith, W. E. & Constantine, N. T. (2005). Detection of ultra-low levels of pathologic prion protein in scrapie infected hamster brain homogenates using real-time immuno-PCR. J Virol Methods 127, 154-164.
2. Bellon, A., Seyfert-Brandt, W., Lang, W., Baron, H., Gröner, A. & Vey, M. (2003). Improved conformation-dependent immunoassay: suitability for human prion detection with enhanced sensitivity. J Gen Virol 84, 1921-1925.
3. Blajchman, M. A., Goldman, M., Webert, K. E., Vamvakas, E. C., Hannon, J. & Delage, G. (2004). Proceedings of a consensus conference: the screening of blood donors for variant CJD. Trans̈fus Med Rev 18, 73-92.
4. Brown, P. & Cervenakova, L. (2004). The modern landscape of transfusion-related iatrogenic Creutzfeldt-Jakob disease and blood screening tests. Curr Opin Hematol 11, 351-356.
5. Bruce, M. E., McConnell, I., Will, R. G. & Ironside, J. W. (2001). Detection of variant Creutzfeldt-Jakob disease infectivity in extra-neural tissues. Lancet 358, 208-209.
6. Cervenakova, L., Brown, P., Soukharev, S., Yakovleva, O., Diringer, H., Saenko, E. L. & Drohan, W. N. (2003). Failure of immunocompetitive capillary electrophoresis assay to detect disease-specific prion protein in buffy coat from humans and chimpanzees with Creutzfeldt-Jakob disease. Electrophoresis 24, 853-859.
7. Sc' via conformationally responsive palindromic PrP peptides. Peptides 26, 2193-2200.
8. Haik, S., Faucheux, B. A., Sazdovitch, V., Privat, N., Kemeny, J.-L., Perret-Liaudet, A. & Hauw, J.-J. (2003). The sympathetic nervous system is involved in variant Creutzfeldt-Jakob disease. Nat Med 9, 1121-1123.
9. Head, M. W., Bunn, T. J. R., Bishop, M. T. & 9 other authors (2004a). Prion protein heterogeneity in sporadic but not variant Creutzfeldt-Jakob disease: U.K. cases 1991-2002. Ann Neurol 55, 851-859.
10. Head, M. W., Ritchie, D., Smith, N. & 7 other authors (2004b). Peripheral tissue involvement in sporadic, iatrogenic, and variant Creutzfeldt-Jakob disease. Am J Pathol 164, 143-153.
11. Hilton, D. A., Fathers, E., Edwards, P., Ironside, J. W. & Zajicek, J. (1998). Prion immunoreactivity in appendix before clinical onset of variant Creutzfeldt-Jakob disease. Lancet 352, 703-704.
12. Hilton, D. A., Ghani, A. C., Conyers, L., Edwards, P., McCardle, L., Penney, M., Ritchie, D. & Ironside, J. W. (2002). Accumulation of prion protein in tonsil and appendix: review of tissue samples. BMJ 325, 633-634.
13. Hilton, D. A., Ghani, A. C, Conyers, L, Edwards, P., McCardle, L., Ritchie, D., Penney, M., Hegazy, D. & Ironside, J. W. (2004). Prevalence of lymphoreticular prion protein accumulation in UK tissue samples. J Pathol 203, 733-739.
14. HPA (2006). New case of transfusion-associated variant-CJD. In CDR Weekly, vol. 16, no. 6. http://www.hpa.org.uk/cdr/archives/archive06/ News/news06O6.htm
15. Hunter, N., Foster, J., Chong, A., McCutcheon, S., Parnham, D., Eaton, S., MacKenzie, C. & Houston, F. (2002). Transmission of prion diseases by blood transfusion. J Gen Virol 83, 2897-2905.
16. Jackman, R. & Schmerr, M. J. (2003). Analysis of the performance of antibody capture methods using fluorescent peptides with capillary zone electrophoresis with laser-induced fluorescence. Electrophoresis 24, 892-896.
17. Jackman, R., Everest, D. J., Schmerr, M. J., Khawaja, R., Keep, P. & Docherty, J. (2006). Evaluation of a preclinical blood test for scrapie in sheep using immunocapillary electrophoresis. J Assoc Off Anal Chem 89, 720-727.
18. Johnson, T. R., Alter, H. J., Cliver, D. O. & 12 other authors (2001). Testing blood for evidence of the agents of transmissible spongiform encephalopathies. In Advancing Prion Science: Guidance for the National Prion Research Program, pp. 108-124. Edited by L. R. Erdtmann & L. B. Sivitz. Washington, DC: National Academies Press.
19. Lane, A., Oliver, J., Quarterman, E., Stanley, C., Dealler, S. & Wilson, S. (2004). Detection of transmissible spongiform encephalopathies in blood. In Proceedings of the First International Conference of the Network of Excellence Neuro Prion, p. 51. Edited by J. P. Deslys, C. I. Lasmezas, J. Schell & S. Simoneau.
20. Llewelyn, C. A., Hewitt, P. E., Knight R. S. G., Amar, K., Cousens, S., Mackenzie, J. & Will, R. G. (2004). Possible transmission of variant Creutzfeldt-Jakob disease by blood transfusion. Lancet 363, 417-421.
21. Minor, P. D. (2004). Technical aspects of the development and validation of tests for variant Creutzfeldt-Jakob disease in blood transfusion. Vox Sang 86, 164-170.
22. Minor, P., Newham, J., Jones, N. & 9 other authors (2004). Standards for the assay of Creutzfeldt-Jakob disease specimens. J Gen Virol 85, 1777-1784.
23. Peden, A. H., Head, M. W., Ritchie, D. L., Bell, J. E. & Ironside, J. W. (2004). Preclinical vCJD after blood transfusion in a PRNP codon 129 heterozygous patient. Lancet 364, 527-529.
24. Safar, J. G., Scott, M., Monaghan, J. & 12 other authors (2002). Measuring prions causing bovine spongiform encephalopathy or chronic wasting disease by immunoassays and transgenic mice. Nat Biotechnol 20, 1147-1150.
25. Schmerr, M. J. & Jenny, A. (1998). A diagnostic test for scrapie-infected sheep using a capillary electrophoresis immunoassay with fluorescent-labeled peptides. Electrophoresis 19, 409-414.
26. Schmerr, M. J. & Alpert, A. J. (2000). Method and kit for extracting prion protein. US patent 6,150,172.
27. Schmerr, M. J., Jenny, A. L., Bulgin, M. S., Miller, J. M., Hamir, A. N., Cutlip, R. C. & Goodwin, K R. (1999). Use of capillary electrophoresis and fluorescent labeled peptides to detect the abnormal prion protein in the blood of animals that are infected with a transmissible spongiform encephalopathy. J Chromatogr A 853, 207-214.
28. Soto, C. (2004). Diagnosing prion diseases: needs, challenges and hopes. Nat Rev Microbiol 2, 809-819.
29. Wadsworth, J. D. F., Joiner, S., Hill, A. F., Campbell, T. A., Desbruslais, M., Luthert, P. J. & Collinge, J. (2001). Tissue distribution of protease resistant prion protein in variant Creutzfeldt-Jakob disease using a highly sensitive immunoblotting assay. Lancet 358, 171-180.
30. Will, R. G., Ironside, J. W., Zeidler, M. & 7 other authors (1996). A new variant of Creutzfeldt-Jakob disease in the UK. Lancet 347, 921-925.
31. Yakovleva, O., Janiak, A., McKenzie, C., McShane, L., Brown, P. & Cervenakova, L. (2004). Effect of protease treatment on plasma infectivity in variant Creutzfeldt-Jakob disease mice. Transfusion 44, 1700-1705.
32. Yang, W.-C., Yeung, E. S. & Schmerr, M. J. (2005a). Detection of prion protein using a capillary electrophoresis-based competitive immunoassay with laser-induced fluorescence detection and cyclodextrin-aided separation. Electrophoresis 26, 1751-1759.
33. Yang, W.-C., Schmerr, M. J., Jackman, R., Bodemer, W. & Yeung, E. S. (2005b). Capillary electrophoresis-based noncompetitive immunoassay for the prion protein using fluorescein-labeled protein A as a fluorescent probe. Anal Chem 77, 4489-4494.